Cyclooxygenase-2 expression during rat neocortical development and in Rett syndrome

Brain and Development

Volumn 19, Issue 1, 1997, Pages 25-34

  Kaufmann, Walter E ^a,b   Worley, Paul F ^a   Taylor, Christopher V ^a   Bremer, Margaret ^c   Isakson, Peter C ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c PFIZER INC   (United States)

Author keywords

Cyclooxygenase 2; Dendrite; Immediate early gene; Monoclonal antibody; Neocortex; Postnatal development; Prostaglandin endoperoxide H synthase 2; Rett syndrome

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; PROSTANOID;

ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN DEVELOPMENT; CONTROLLED STUDY; DENDRITIC SPINE; HISTOCHEMISTRY; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMEDIATE EARLY GENE; IMMUNOCYTOCHEMISTRY; MALE; NEOCORTEX; NONHUMAN; POSTNATAL DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RETT SYNDROME; SIGNAL TRANSDUCTION; SOMATOSENSORY CORTEX; SYNAPTIC TRANSMISSION; VISUAL CORTEX;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; CYCLOOXYGENASE 2; DENDRITES; FEMALE; GENES, IMMEDIATE-EARLY; HAPLORHINI; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RETT SYNDROME;

EID: 0031051604     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(96)00047-2     Document Type: Article

References (47)

1. Bayer SA, Altman J. Neocortical Development. New York: Raven Press, 1991.
2. McConnell SK. Development and decision-making in the mammalian cerebral cortex. Brain Res. Rev. 1988; 13: 1-23.
3. Goodman CS, Shatz CJ. Developmental mechanisms that generate precise patterns of neuronal connectivity. Cell/Neuron 1993; 72/10 (Suppl.): 77-98.
4. Patterson PH, Nawa H. Neuronal differentiation factors/cytokines and synaptic plasticity. Cell/Neuron 1993; 72/10 (Suppl.): 123-137.
5. Hockfield S, Kalb RG. Activity dependent structural changes during neuronal development. Curr. Opin. Neurobiol. 1993; 3: 87-92.
6. Greenough WT. Structural correlates of information storage in the mammalian brain: a review and hypothesis. Trends Neorosci. 1984; 7: 229-233.
7. Worley PF, Cole AJ, Murphy TH et al. Synaptic regulation of immediate-early genes in brain. Cold Spring Harbor Symp. Quant. Biol. 1990; 55: 213-223.
8. Kaufmann WE, Yamagata K, Andreasson KI et al. Rapid response genes as markers of cellular signaling during cortical histogenesis: their potential in understanding mental retardation. Int. J. Dev. Neurosci. 1994; 12: 263-271.
9. Yamagata K, Andreasson KI, Kaufmann WE et al. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993; 11: 371-386.
10. Yamagata K, Kaufmann WE, Lanahan A et al. Egr3/Pilot, a zincfinger transcription factor, is rapidly regulated by activity in brain neurons and co-localizes with Egrl/zif268. Learning Memory 1994; 1: 140-152.
11. Yamagata K, Sanders LK, Kaufmann WE et al. rheb, a growth factor-and synaptic activity-regulated gene, encodes a novel Ras-related protein. J. Biol. Chem. 1994; 269: 16333-16339.
12. Lyford GL, Yamagata K, Kaufmann WE et al. Arc, a growth factor and activity-regulated gene encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 1995; 13: 433-445.
13. Andreasson KI, Worley PF. Induction of β-A activin expression by synaptic activity and during neocortical development. Neuroscience 1995; 69: 781-796.
14. Tsui CC, Copeland NG, Gilbert DJ et al. Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity. J. Neurosci. 1996; 16: 2463-2478.
15. Kaufmann WE, Worley PF, Pegg J et al. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. USA 1996; 93: 2317-2321.
16. Smith WL, Marnett LJ, DeWitt DL. Prostaglandin and thromboxane biosynthesis. Pharmacol. Ther. 1991; 49: 153-179.
17. Salvemini D, Misko TP, Masferrer JL et al. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 1993; 90: 7240-7244.
18. Pourcyrous M, Leffler CW, Mirro R et al. Brain Superoxide anion generation during asphyxia and reventilation in newborn pigs. Pediatr. Res. 1990; 28: 618-621.
19. Petit TL, LeBoutillier JC, Gregorio A et al. The pattern of dendritic development in the cerebral cortex of the rat. Dev. Brain Res. 1988; 41: 209-219.
20. Kaufmann WE. Mental retardation and learning disorders. A neuropathologic differentiation. In: Capute AJ, Accardo PJ, eds. Developmental Disabilities in Infancy and Childhood. Vol. II. The Spectrum of Developmental Disabilities. Baltimore: Brookes Publishing, 1996; 49-70.
21. Naidu S, Hyman S, Harris E et al. Rett syndrome studies of natural history and search for a genetic marker. Neuropediatrics 1995; 26: 63-66.
22. Bauman ML, Kemper TL, Arin DM. Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome. Neurology 1995; 45: 1581-1586.
23. Armstrong DA, Dunn JK, Antalffy B et al. Selective dendritic alterations in the cortex of Rett syndrome. J. Neuropathol. Exp. Neural. 1995; 54: 195-201.
24. Evers P, Uylings HBM. Microwave-stimulated antigen retrieval is pH and temperature dependent. J. Histochem. Cytochem. 1994; 42: 1555-1563.
25. Kaufmann WE, Naidu S, Budden S. Abnormal expression of microtubule-associated protein 2 (MAP-2) in neocortex in Rett syndrome. Neuropediatrics 1995; 26: 109-113.
26. Kaufmann WE, Naidu S. Is Rett syndrome a subplate disease? Soc. Neurosci. Abstr. 1995; 21: 735.
27. Matus A, Riederer B. Microtubule-associated proteins in the developing brain. Ann. N.Y. Acad. Sci. 1986; 486: 167-179.
28. Tucker RP, Garner CC, Matus A. In situ localization of microtubule-associated protein mRNA in the developing and adult rat brain. Neuron 1989; 2: 1245-1256.
29. Kanai Y, Hirokawa N. Sorting mechanisms of Tau and Map2 in neurons: suppressed axonal transit of MAP2 and locally regulated microtubule binding. Neuron 1995; 14: 421-432.
30. Campbell MJ, Morrison JH. Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. J. Comp. Neurol. 1989; 282: 191-205.
31. Shaw G, Weber K. Differential expression of neurofilament triplet proteins in brain development. Nature 1982; 298: 277-279.
32. Hedreen JC, Mucci LA. Antigen retrieval for paraffin section immunocytochemistry with antibodies commonly used in studies of degenerative diseases. Soc. Neurosci. Abstr. 1995; 21: 1802.
33. Blue ME, Parnavelas JG. The formation and maturation of synapses in the visual cortex of the rat. II. Quantitative analysis. J. Neurocytol. 1983; 12: 697-712.
34. Faglioni M, Pizzorusso T, Berardi N et al. Functional postnatal development of the rat primary visual cortex and the role of visual experience: dark rearing and monocular deprivation. Vision Res. 1994; 34: 709-720.
35. Hertting G, Seregi A. Formation and function of eicosanoids in the central nervous system. Ann. N.Y. Acad. Sci. 1989; 559: 84-99.
36. Dumuis A, Sebben L, Haynes L et al. NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 1988; 336: 68-70.
37. Williams JH, Errington ML, Lynch MA et al. Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus. Nature 1989; 341: 739-742.
38. Lerea LS, McNamara JO. lonotropic glutamate receptor subtypes activate c-fos transcription by distinct calcium-requiring intracellular signaling pathways. Neuron 1993; 10: 31-41.
39. Breder CD, Dewitt D, Kraig RP. Characterization of inducible cyclooxygenase in rat brain. J. Comp. Neurol. 1995; 355: 296-315.
40. Kemper TL. Neuropathology of Down syndrome. In: Nadel L, ed. The Psychobiology of Down Syndrome. Cambridge, MA: MIT Press, 1988; 269-289.
41. Kaufmann WE, Hohmann CF, Israel JJ et al. Microtubule-associated protein 2 is abnormally expressed in the neocortex of Rett syndrome subjects and in a related animal model. Ann. Neurol. 1995; 38: 500.
42. Vane JR, Botting R. Inflammation and the mechanisms of action of anti-inflammatory drugs. FASEB J. 1987; 1: 89-96.
43. Nakayama M, Chen J, Lowry T et al. The immediate-early gene cyclooxygenase-2 is expressed in CA1 neurons destined for apoptotic death following global ischemia. Soc. Neurosci. Abstr. 1995; 21: 1268.
44. Baran H, Vass K, Lassmann H et al. The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid-induced seizures and neurotoxicity. Brain Res. 1994; 646: 201-206.
45. Earnest DL, Hixson LJ, Alberts DS. Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J. Cell Biochem. 1992; 161S: 156-166.
46. McGeer PL, Rogers J, McGeer EG. Neuroimmune mechanisms in Alzheimer disease pathogenesis. Alzheimer Dis. Assoc. Disord. 1994; 8: 149-158.
47. Corrada M, Stewart W, Kawas C. Non-steroidal anti-inflammatory drugs and the risk of Alzheimer's disease. Neurology 1996; 46: A433.